Start Date
August 31, 2023
Primary Completion Date
January 31, 2025
Study Completion Date
May 31, 2025
Egito
EGITO Egito coated tablet. EMPAGLIFLOZIN PLACEBO Empagliflozin placebo coated tablet. TELMISARTAN PLACEBO Telmisartan coated tablet.
Empagliflozin + telmisartan
Drug: EMPAGLIFLOZIN Empagliflozin 25 mg coated tablet. Drug: TELMISARTAN Telmisartan 40/80 mg coated tablet. EGITO PLACEBO Egito placebo coated tablet.
Lead Sponsor
EMS
INDUSTRY